Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fresenius Kabi Acquires Ivenix For $240M To Expand Presence In Infusion Pump Market

Apr 04 2022

• By David Wallace and Reed Miller

business handshake — • Source: Alamy

Related Content

Fresenius Nod In EU Adds To Crowded Adalimumab Market

Feb 08 2019

Fresenius Kabi Unveils 2026 Strategy With Focus On Business Not Region

Nov 05 2021

Fresenius Kabi Takes Control Of mAbxience To Bolster Biosimilars

Mar 31 2022

Accord’s Teriparatide And Fresenius Kabi’s Pegfilgrastim Satisfy CHMP

Jan 31 2022

Fresenius Puts Kabi At The Top As It Ponders Best Use Of Cash

Feb 24 2022

Related Companies

Fresenius Kabi AG

mAbxience S.L.

Fresenius SE & Co. KGaA

Additional Topics

M & A Drug Delivery Technology Business Strategies Deals Strategy Biosimilars Commercial BioPharmaceutical Medical Device

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window